Evaluation of the Food and Drug Administration's 'Fresh Empire' Multicultural Youth Tobacco Prevention Campaign.

ICR 201701-0910-001

OMB: 0910-0788

Federal Form Document

Forms and Documents
Document
Name
Status
Supplementary Document
2017-01-03
Justification for No Material/Nonsubstantive Change
2017-01-03
Supplementary Document
2016-03-22
Supplementary Document
2017-01-03
Supplementary Document
2017-01-03
Supplementary Document
2016-03-22
Supplementary Document
2016-03-22
Supplementary Document
2017-01-03
Supplementary Document
2016-03-22
Supplementary Document
2016-03-22
Supplementary Document
2017-01-03
Justification for No Material/Nonsubstantive Change
2016-03-22
Supporting Statement B
2017-01-03
Supporting Statement A
2017-01-03
ICR Details
0910-0788 201701-0910-001
Historical Active 201603-0910-010
HHS/FDA CTP
Evaluation of the Food and Drug Administration's 'Fresh Empire' Multicultural Youth Tobacco Prevention Campaign.
No material or nonsubstantive change to a currently approved collection   No
Regular
Approved without change 01/09/2017
Retrieve Notice of Action (NOA) 01/09/2017
  Inventory as of this Action Requested Previously Approved
05/31/2018 05/31/2018 05/31/2018
74,950 0 106,648
10,206 0 13,678
0 0 0

The Food and Drug Administration (FDA) requests Office of Management and Budget (OMB) approval to conduct in-person and Web-based surveys of multicultural youth in the United States, as the Evaluation of the Fresh Empire Campaign on Tobacco (EFECT). These surveys will be fielded for purposes of evaluating FDA’s Fresh Empire public education campaign for multicultural youth 12 to 17 years old. The primary outcome evaluation will consist of a pre-test survey and cross-sectional post-test surveys with an embedded longitudinal cohort in campaign and control cities beginning approximately 6 months following the campaign launch. Data from this evaluation will be used to gauge campaign awareness and examine the statistical relationships between exposure to the campaign and changes in outcome variables of interest.

PL: Pub.L. 111 - 31 1003(d)(2)(D) Name of Law: Federal Food, Drug, and Cosmetic Act
  
None

Not associated with rulemaking

  80 FR 230 01/05/2015
80 FR 19673 04/13/2015
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 74,950 106,648 0 0 -31,698 0
Annual Time Burden (Hours) 10,206 13,678 0 0 -3,472 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
No
No
No burden change - ICs were restructured for organizational purposes.

$8,037,087
Yes Part B of Supporting Statement
No
No
No
No
Uncollected
Amber Sanford 301 796-8867 amber.sanford@fda.hhs.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
01/09/2017


© 2024 OMB.report | Privacy Policy